Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Imaging|April 10, 2009
Imaging highlights from the European Society of Cardiology, American Society of Nuclear Cardiology, and Heart Failure Society of AmericaJuhani Knuuti, Don Poldermans, James E Udelson, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 1, 2005
New hybrid count- and geometry-based method for quantification of left ventricular volumes and ejection fraction from ECG-gated SPECT: methodology and validationYi-Hwa Liu, Albert J Sinusas, Daniel Khaimov, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionStanley Chia, Fred Senatore, O Christopher Raffel, et al.
The Journal of Cardiovascular Nursing|April 8, 2006
The impact of screening for asymptomatic myocardial ischemia in individuals with type 2 diabetesDeborah A Chyun, Deborah M Katten, Gail D Melkus, et al.
International Journal of Cardiology|September 18, 2012
The heart rate response to adenosine: a simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetesFadi G Hage, Frans J Th Wackers, Shanti Bansal, et al.
Diabetes Care|October 9, 2010
Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysisShanti Bansal, Frans J Th Wackers, Silvio E Inzucchi, et al.
Biological Research for Nursing|April 4, 2006
The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetesDeborah A Chyun, Gail D Melkus, Deborah M Katten, et al.
The American Journal of Cardiology|January 27, 2009
Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarctionStanley Chia, John T Nagurney, David F M Brown, et al.
Journal of Thrombosis and Thrombolysis|November 2, 2005
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) studyIk-Kyung Jang, Veronica Pettigrew, Michael H Picard, et al.
SAGE Open Medicine|January 16, 2016
Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD studyDeborah A Chyun, Frans J Th Wackers, Silvio E Inzucchi, et al.
Pageof 4